Vizgen, Inc., a life science company dedicated to improving human health by visualizing single-cell spatial genomics information, and Ultivue, Inc., a market leader in multiplex proteomic biomarker detection and advanced AI-driven spatial tissue profiling, announce a merger. The companies are combining to establish a single organization uniquely positioned to drive future technology breakthroughs and respond to researchers’ desire for unified solutions in spatial multi-omics. Concurrent with the merger, Vizgen also announced completion of its Series D round of new equity financing. The company continues to be supported by a global syndicate of leading investors in the life sciences.
Read the full article: Vizgen and Ultivue Merge to Enable Deeper Insights into Disease Mechanisms and Drive Innovation in Spatial Multi-Omics //
Source: https://vizgen.com/vizgen-and-ultivue-merge-to-enable-deeper-insights-into-disease-mechanisms-and-drive-innovation-in-spatial-multi-omics/